Abstract

The periaqueductal gray (PAG) region of the midbrain has been implicated in both stimulation produced and opioid induced analgesia. In the present study the opioid binding characteristics of the PAG were examined with an in vitro radioligand binding technique. [ 3H]Ethylketocyclazocine (EKC), 2 nM, was useed as a ligand to nonselevtively labels μ, δ, and κ binding sites in PAG enriched P 2 membrane. The μ selective ligand [D-Ala 2, N-methylPhe 4, Glyol 5]enkephalin (DAGO) competed with [ 3H]EKC for more than one population of binding sites with both high and low affinity. In contrast the δ selective ligand [D-Pen 2, D,-Pen 5]enkephalin (DPDPE) and the κ selective ligand trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide, methane sulfonate, hydrate (U50,488H) each competed with [ 3H]EKC for a single population of binding of sites with low affinity. DPDPE and U50,488H also competed with 2 nM [ 3H]DAGO for a single population of binding sites with similar low affinity. DAGO and not DPDPE competed with 2 nM [ 3H][D-Ala 2,D-Leu 5]enkephalin (DADLE) with high affinity. 2 nM [ 3H]DPDPE did not substantially label PAG enriched P 2 membrane, and 1 nM DAGO competed with all specific [ 3H]DPDPE binding which was observed. These binding data are consistent with the presence of a single population of μ selective high affinity binding sites in PAG enriched P 2 membrane to which δ ligands and κ ligands have low affinity.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.